Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - Pharmaceutical News - Eighty-Seven Organizations Call on Congress to Protect Medicaid - September 19, 2017

Pharmacy News Article

 3/20/17 - Eighty-Seven Organizations Call on Congress to Protect Medicaid

BETHESDA, Md.(BUSINESS WIRE) Eighty-seven organizations issued a letter today calling on Congress to take a hard look at the likely significant and life-threatening consequences of the American Health Care Act on millions of patients. The organizations represent Americans with complex health needs who rely on Medicaid for access to care, prevention and treatment.

For example, Medicaid supports:

  • Roughly half of all births helping pregnant woman and infants receive care;
  • Nearly a third of pediatric cancer patients; and
  • Half of children and a third of adults with cystic fibrosis.

The American Health Care Act would cut Medicaid funds and reduce eligibility with the goal of cost savings, but at the expense of patients who rely on this vital safety net for their life-sustaining health care needs. Millions of patients would be left without Medicaid coverage under this proposal, threatening their ability to maintain their health and well-being. We implore Congress to take urgent action to protect constituents and communities across the nation.

See below for the full text of the letter and complete list of organizations that signed on.

March 20, 2017

The Honorable Mitch McConnell
Senate Majority Leader
U.S. Capitol Building, S-230
Washington DC 20510

The Honorable Paul Ryan
Speaker of the House
U.S. Capitol Building, H-232
Washington, DC 20515

Dear Leader McConnell and Speaker Ryan:

The undersigned organizations write to express grave concern about proposals put forth in the American Health Care Act (AHCA) to alter the fundamental structure and purpose of Medicaid, a vital source of health care for patients with ongoing health needs.

We feel compelled to speak out against proposals to phase out Medicaid expansion and implement per capita caps, which threaten the ability of Medicaid to provide critical health care services to many of our most vulnerable citizens. These proposals aim to achieve cost savings of approximately $880 billion, according to the Congressional Budget Office, at the expense of tens of millions of patients who rely on Medicaid for life-sustaining care.1 While we appreciate the opportunities we have had to work with your staff, we cannot support the Medicaid provisions in this bill and cannot accept policies that prioritize cutting costs by limiting patients access to care.

Medicaid is Critical for Patients
Medicaid is a crucial source of coverage for patients with serious and chronic health care needs. Pregnant women depend on Medicaid, which covers roughly 50 percent of all births including many high-risk pregnancies.2 Medicaid covers cancer patients: nearly one-third of pediatric cancer patients were enrolled in Medicaid in 2013 and approximately 1.52 million adults with a history of cancer were covered by Medicaid in 2015.3 Over fifty percent of children and one-third of adults living with cystic fibrosis rely on Medicaid to get the treatments and therapies they need to preserve their health.4 Nearly half of children with asthma are covered by Medicaid or CHIP and adults with diabetes are disproportionally covered by Medicaid as well.5,6 The patients we represent are eligible for Medicaid through various pathways, including through income-related and disability criteria.

Reject Per Capita Caps
The proposal to convert federal financing of Medicaid to a per capita cap system is deeply troubling. This policy is designed to reduce federal funding for Medicaid, forcing states to either make up the difference with their own funds or cut their programs by reducing the number of people they serve and the health benefits they provide.

For patients with ongoing health care needs, this means that Medicaid may no longer cover the care and treatments they need, including breakthrough therapies and technology. In order to save money, the per capita caps are set to grow more slowly than expected Medicaid costs under current law.7 As the gap between the capped allotment and actual costs increases over time, states will be forced to constrain eligibility, reduce benefits, lower provider payments, or increase cost-sharing. Moreover, by capping the federal government's contribution to Medicaid in this manner, states will be less able to cover the cost of new treatments. This could be devastating for people with serious diseases, for whom groundbreaking treatments represent a new lease on life. For people with cystic fibrosis, cancer, and other diseases, new therapies can be game changers that improve quality of life and increase life expectancy. In fact, we have already seen Medicaid programs respond to current budget constraints by using clinically inappropriate criteria to restrict access to therapies old and new. A per capita cap will only exacerbate the downward pressure on Medicaid budgets and will further reduce access to these therapies for patients.

Pairing financing reforms with increased flexibility, as has often been proposed, would further undermine Medicaid's role as a safety net for patients. Without current guardrails provided by federal requirementscoupled with reduced federal funding'states will have the authority to reduce benefits and eligibility as they see fit and to impose other restrictions, such as waiting periods and enrollment caps. These policies have serious implications for patientsfor a person with cancer, enrollment freezes and waiting lists could mean a later-stage diagnosis when treatment costs are higher and survival is less likely. For a person with diabetes, this would risk the ability to adequately manage the disease. Many of our patients rely on costly services that will be quickly targeted for cuts if states are given such flexibility, so it is imperative that current federal safeguards remain in place.

Maintain Medicaid Expansion
While the AHCA has been described as preserving Medicaid expansion for those already enrolled in coverage, we are concerned that estimates show that eliminating the enhanced match for any enrollee with even a small gap in coverage would actually result in millions of people losing coverage.8,9 By eliminating the enhanced federal match for any enrollee with a gap in coverage, eventually states will be on the hook for billions of dollars to continue covering this populationan insurmountable financial hurdle. Additionally, seven states have laws that would effectively end Medicaid expansion immediately or soon thereafter when the expansion match rate is eliminated. Nearly half of adults covered by the Medicaid expansion are permanently disabled, have serious physical or mental conditions'such as cancer, stroke, heart disease, arthritis, pregnancy, or diabetesor are in fair or poor health.11 Repealing Medicaid expansion will leave these patients without coverage they depend upon to maintain their health.

The proposed financing reforms are a fundamental shift away from Medicaid's role as a safety-net for some of the most vulnerable members of our society. Repealing Medicaid expansion would leave millions without the health care they rely on. Our organizations represent and provide care for millions of Americans living with ongoing health care needs who rely on Medicaid and we cannot support policies that pose such a grave risk to patients.

We hope that we can continue our dialogue as you move forward in this process to arrive at solutions that provide all Americans with high-quality, affordable care regardless of an individual's income, employment status, health status, or geographic location.

Sincerely,

ADAP Advocacy Association
AIDS Action Baltimore
The AIDS Institute
Alpha-1 Foundation
Alport Syndrome Foundation
ALS Association
American Academy of Pediatrics
American Behcet's Disease Association
American Congress of Obstetricians and Gynecologists
American Diabetes Association
American Lung Association
American Parkinson Disease Association
American Society of Hematology
American Thoracic Society
Amyloidosis Support Groups Inc.
ARPKD/CHF Alliance
Arthritis Foundation
Batten Disease Support & Research Association
Bladder Cancer Advocacy Network
Bridge the Gap - SYNGAP Education and Research Foundation
Bronx Lebanon Hospital Center Department of Family Medicine
CADASIL Together We Have Hope Non-Profit
Cancer Support Community
Child Neurology Foundation
Children's Cause for Cancer Advocacy
Children's Dental Health Project
Chronic Illness and Disability Partnership
Community Access National Network
Congenital Adrenal Hyperplasia Research Education & Support Foundation, Inc.
COPD Foundation
Cure HHT
Cutaneous Lymphoma Foundation
Cystic Fibrosis Foundation
Cystinosis Research Network
debra of America
Endocrine Society
Fibrous Dysplasia Foundation
First Focus Campaign for Children
FORCE: Facing Our Risk of Cancer Empowered
Foundation for Prader-Willi Research
Friedreich's Ataxia Research Alliance (FARA)
Genetic Alliance
Hannah's Hope Fund
Hide & Seek Foundation for Lysosomal Disease Research
Hispanic Health Network
Hope for Hypothalamic Hamartomas
Huntington's Disease Society of America
Immune Deficiency Foundation
The International Pemphigus and Pemphigoid Foundation
Kids v Cancer
Latino Commission on AIDS
LFS Association (Li-Fraumeni Syndrome Association)
Liver Health Connection
March of Dimes
Medicare Rights Center
MLD Foundation
Moebius Syndrome Foundation
Muscular Dystrophy Association (MDA)
NASTAD (National Alliance of State & Territorial AIDS Directors)
National Alliance on Mental Illness
National Coalition for Cancer Survivorship
National Health Law Program
National Hemophilia Foundation
National Multiple Sclerosis Society
National Organization for Rare Disorders
National Patient Advocate Foundation
National Tay-Sachs & Allied Diseases Association (NTSAD)
National Urea Cycle Disorders Foundation
National Viral Hepatitis Roundtable
NBIA Disorders Association
Needle Exchange Emergency Distribution (NEED)
Parent Project Muscular Dystrophy (PPMD)
Parkinson Alliance
The PCD (Primary Ciliary Dyskinesia) Foundation
Polycystic Kidney Disease Foundation
Pulmonary Fibrosis Foundation
PXE International
Rett Syndrome Research Trust
Scleroderma Foundation
The Sudden Arrhythmia Death Syndromes Foundation
T1D Exchange
Trisomy 18 Foundation
Tuberous Sclerosis Alliance
United Way Worldwide
VHL Alliance
Wilson Disease Association
Wishes for Elliott: Advancing SCN8A Research
CC: Senate Minority Leader Charles E. Schumer
Senate Finance Committee Chairman Orrin Hatch
Senate Finance Committee Ranking Member Ron Wyden
House Minority Leader Nancy Pelosi
House Energy and Commerce Committee Chair Greg Walden
House Energy and Commerce Committee Ranking Member Frank Pallone
Secretary of Health and Human Services Thomas Price

1 Congressional Budget Office. Cost Estimate: American Health Care Act. (Online). March 2017. Available: https://www.cbo.gov/publication/52486
2 March of Dimes. Maternity and Newborn Care in Medicaid. (Online). Feb 2017. Available: http://www.marchofdimes.org/materials/March-of-Dimes-Maternity-and-Newborn-Care-in-Medicaid-Feb2017.pdf
3 American Cancer Society. Estimate of Adults with a History of Cancer Covered by Medicaid in 2015. January 2017., National Center for Health Statistics. National Health Interview Survey. 2015., NPCR: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 19992013 Incidence and Mortality Web-based Report. 2016.
4 Cystic Fibrosis Foundation Patient Registry. 2015 Annual Data Report. (Online). 2016. Available: https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf
5 Centers for Disease Control and Prevention. Asthma: Health Care Coverage Among Children. (Online). November 2016. Available: https://www.cdc.gov/asthma/asthma-stats/
6 Kaiser Commission on Medicaid and the Uninsured. The Role of Medicaid for People with Diabetes. (Online). November 2012. Available: http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8383-d.pdf
7 Congressional Budget Office. Cost Estimate: American Health Care Act. (Online). March 2017. Available: https://www.cbo.gov/publication/52486
8 S&P Global Market Intelligence. The U.S. Health Insurance Market is Poised to Move to a Defined-Contribution from a Defined-Benefit System of Federal Financing. (Online). March 2017. Available: https://www.globalcreditportal.com/ratingsdirect/renderArticle.do?articleId=1811131&SctArtId=418648&from=CM&nsl-code=LIME&sourceObjectId=10006958&sourceRevId=3&fee-ind=N&exp-date=20270307-22:26:18
9 Congressional Budget Office. Cost Estimate: American Health Care Act. (Online). March 2017. Available: https://www.cbo.gov/publication/52486 11 Brantley, Erin, et. al. Myths About the Medicaid Expansion and the Able-Bodied. Health Affairs Blog. (Online) March 2017. Available: http://healthaffairs.org/blog/2017/03/06/myths-about-the-medicaid-expansion-and-the-able-bodied/

American Diabetes Association

Michelle Kirkwood, 703-299-2053

Director, Strategic Communications & Media Relations

mkirkwood@diabetes.org

or

American Lung Association

Allison MacMunn, 312-801-7628

National Director, Media Relations

media@Lung.org

or

Cystic Fibrosis Foundation

Jessica Rowlands, 240-482-2857

Senior Director, Communications and Media Relations

jrowlands@cff.org

or

March of Dimes

Cynthia Pellegrini, 202-292-2747

Senior Vice President, Public Policy & Government Affairs

cpellegrini@marchofdimes.org

or

National Alliance on Mental Illness

Lauren Gleason, 703-516-7230

Director, Public Relations & Media

media@nami.org

or

National MS Society

Eileen Curran, 617-719-3202

Senior Director, Communications and PR

eileen.curran@nmss.org

or

National Organization for Rare Disorders

Jennifer Huron, 203-304-7258

Associate Director, Communications & Marketing

jhuron@rarediseases.org

Source: Cystic Fibrosis Foundation



Copyright Business Wire 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 20: What's New? New Treatments for Type 2 Diabetes
Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415